婴儿结肠与晚期便秘和亚托皮性疾病的发展有关
Jakob Stokholm1,2,3, Jonathan Thorsen1, Ann-Marie Malby Schoos1,3
1Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
Allergy
|August 20, 2024
概括
婴儿大肠与患上便秘和在幼儿时期患喘和湿疹等类型疾病的风险更高有关. 这些风险并不能用婴儿1个月大时肠道微生物组的差异来解释.
科学领域:
- 儿科健康 儿科健康
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
背景情况:
- 婴儿结肠是一种常见的疾病,其长期健康影响尚不清楚.
- 对于早期生活肠道微生物组与以后的亚托皮性或胃肠道疾病之间的联系的理解有限.
研究的目的:
- 为了研究早期生活肠道微生物组在婴儿大肠中的作用.
- 评估婴儿结肠和随后的阿托皮和胃肠道疾病的发展之间的联系,直到6岁.
主要方法:
- 利用哥本哈根前性儿童喘研究 (2010) 队列,在6年内跟踪695名儿童.
- 通过16S rRNA测序分析了1个月的肠道微生物组,并在三个月后通过采访评估了婴儿结肠.
- 评估的临床终点包括便秘,喘,亚托皮炎和过敏敏感性到6岁.
主要成果:
- 婴儿结肠发作发生在7.9%的儿童中;虽然与特定的微生物组合没有直接联系,但九种物种的模型中度预测了结肠发作 (AUC=0.627).
- 患有婴儿的儿童出现后来的便秘风险增加 (aOR=2.88),喘 (aHR=1.69),亚托皮炎 (aHR=1.84),以及更多的过敏成分.
- 这些关联并非由一个月大时的肠道微生物群差异介导.
结论:
- 婴儿结肠与在生命的前六年内患上便秘和亚托皮性疾病的风险增加有关.
- 观察到的风险并不能通过1个月大时肠道微生物组的改变来解释.
- 这些发现表明,婴儿结肠可能涉及潜在的胃肠道和/或亚托皮机制,独立于早期微生物组合.
相关概念视频
Chronic Bowel Disorders: Introduction
427
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
427
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
154
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
154
Inflammatory Bowel Disease I: Ulcerative Colitis
160
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
160
Inflammatory Bowel Disease II: Crohn's Disease
206
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
206
Drugs for Treatment of Constipation-Predominant IBS
146
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
146
Irritable Bowel Syndrome I: Introduction
264
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
264


